Venue | Press Room | Subscribe | Site Map
TechConnect Summit 2006
Home | About the Summit | Program | Advisory Boards | About TechConnect

Producing Sponsor


Platinum Sponsor

Welsh & Katz, Ltd.

Gold Sponsor

ISTC International Science & Technology Center

Ventures Enabling Sponsor

Atomic Venture Partners

Press Sponsor

Business Wire

Partnering Sponsor


Supporting Organizations

Boston University
Midwest Research University Network

Media Sponsors

(joint with Nanotech 2006) Nature
R&D Magazine

Summit News

Event Contact

Jennifer Rocha
955 Massachusetts Ave. #313
Cambridge, MA 02139
Phone: (774) 249-8514

NanoBioMagnetics, Inc (NBMI)

Location:OK, US
Speaker:Charles Seeney
Title:President & CEO
Primary Industry:Nanobiotechnology
Executive Summary:NanoBioMagnetics, Inc. (NBMI) is a development stage nanobiomaterials company pioneering an emerging area of nanomedicine referred to as organ-assisting-device (OAD) technologies. The company’s core technology is based on an electromagnetic methodology for the site-specific placement of designed constructs of magnetically responsive nanoparticles (MNP) in driving a desired physiological event. Based on a proprietary nanofabrication platform, proprietary application platforms under development include: (1) Biostable Implant Devices, in which implanted MNP drive tissue movements in an oscillating magnetic field, and (2) Vectored Drug Delivery, in which MNP constructs, carrying a therapeutic load, are magnetically vectored to the site of therapeutic need. NBMI’s OAD technologies, site-specific and organ-specific in function, are viewed as enabling technologies that will enhance and expand the range of therapeutic options over a spectrum of human health disorders. Several OAD applications, in scientific firsts, have been experimentally validated and are being advanced through collaborations with major institutions that bring together multi-disciplinary, world-class science teams with the skills necessary for nanobioconvergence. NBMI is seeking investors and commercialization partners to support and advance the company’s OAD technologies and transition the company from a science organization to a functional business unit.
Venture is:Seed Level


Home | About the Summit | Program | Advisory Boards | About TechConnect
Terms of use | Privacy policy | Contact | TechConnect Home
© 2005 TechConnect. All rights reserved.